Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.43 |
| ▸ | PIN4 | Q9Y237 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 5/20 | 0.38 |
| ▸ | APAF1 | O14727 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | RGS12 | O14924 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL859822 | 0.83 | ALDH1A1 (0.47) | KMT2AKDM4EALDH1A1MEN1HPGD | |
| SCHEMBL29838651 | 0.83 | ALDH1A1 (0.47) | KMT2AKDM4EALDH1A1MEN1HPGD | |
| SCHEMBL13814011 | 0.80 | CA9 (0.49) | KMT2AKDM4EALDH1A1HPGDPOLB | |
| SCHEMBL5865650 | 0.79 | PIN1 (0.51) | NPC1RAB9AL3MBTL1PIN1PIN4 | |
| SCHEMBL859692 | 0.78 | POLB (0.60) | KMT2AKDM4EALDH1A1MEN1HPGD | |
| SCHEMBL860092 | 0.78 | ALDH1A1 (0.49) | KMT2AALDH1A1HPGDHSD17B10POLB | |
| SCHEMBL859502 | 0.76 | ALDH1A1 (0.54) | L3MBTL1KMT2AKDM4EALDH1A1MEN1 | |
| SCHEMBL8087968 | 0.76 | ALDH1A1 (0.33) | NPC1RAB9AL3MBTL1ALDH1A1HPGD | |
| SCHEMBL3684899 | 0.75 | ALDH1A1 (0.56) | NPC1RAB9AKMT2AALDH1A1MEN1 | |
| SCHEMBL13814012 | 0.75 | ALDH1A1 (0.43) | KMT2AKDM4EALDH1A1MEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1433527-B1 | CATALYSTS COMPRISED OF N-SUBSTITUTED CYCLIC IMIDES AND PROCESSES FOR PREPARING ORGANIC COMPOUNDS WITH THE CATALYSTS | DAICEL CHEM (JP) | 2013-11-06 | — | — | EP | disclosed |
| US-20060229196-A1 | Catalyst comprising n-substituted cyclic imide compound and process for producing organic compounds using the catalyst | ISHII YASUTAKA | 2006-10-12 | — | — | US | disclosed |
| US-7084090-B2 | Catalyst comprised of n-substituted cyclic imides and processes for preparing organic compounds with the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-01 | — | — | US | disclosed |
| EP-1433527-A1 | CATALYSTS COMPRISED OF N-SUBSTITUTED CYCLIC IMIDES AND PROCESSES FOR PREPARING ORGANIC COMPOUNDS WITH THE CATALYSTS | Daicel Chemical Industries, Ltd. (JP) | 2004-06-30 | — | — | EP | disclosed |
| US-20040053778-A1 | Catalyst comprised of n-substituted cyclic imides and processes for preparing organic compounds with the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060229196-A1 | Catalyst comprising n-substituted cyclic imide compound and process for producing organic compounds using the catalyst | NOS2, NOS1, NOS3 | NPC1 3823/4885RAB9A 3062/4885L3MBTL1 4496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.